Filter
740
Filtered Results: 740
Text search:
World
Health
Organization,
Government
of
the
Republic
of
Mali
Featured
Recommendations
47
New Publications
207
Language
Document type
No document type
401
Studies & Reports
207
Guidelines
47
Manuals
41
Strategic & Response Plan
30
Situation Updates
7
Training Material
3
Fact sheets
2
Brochures
1
Infographics
1
Countries / Regions
Global
66
Africa
41
Liberia
31
Sierra Leone
29
Guinea
25
Ethiopia
21
Kenya
21
Uganda
20
Nigeria
17
Congo, Democratic Republic of
17
Ghana
16
West and Central Africa
15
Mali
13
Philippines
12
Syria
12
Zambia
11
Tanzania
11
Myanmar / Burma
11
Malawi
10
Senegal
9
South Sudan
9
South Africa
9
Mozambique
9
East and Southern Africa
9
Rwanda
8
Yemen
8
Western and Central Europe
8
Indonesia
7
Central African Republic
7
Ukraine
7
Asia
7
Côte d’Ivoire / Ivory Coast
6
Cameroon
6
India
6
Afghanistan
6
Bangladesh
6
Middle East and North Africa
6
Burkina Faso
5
Somalia
5
Namibia
5
Togo
4
Zimbabwe
4
Haiti
4
Nepal
4
Benin
4
Botswana
4
Latin America and the Carribbean
4
Guinea-Bissau
3
Pakistan
3
Chad
3
Gambia
3
Sudan
3
South–East Asia Region
3
Eastern Europe
3
Tajikistan
3
Niger
2
Germany
2
Cambodia
2
Eswatini/ Swaziland
2
Brazil
2
Colombia
2
Libya
2
Eastern Europe and Central Asia
2
Russia
2
Moldova
2
Kazakhstan
2
Iraq
1
Jordan
1
Ecuador
1
Greece
1
Angola
1
Madagascar
1
Lesotho
1
Mexico
1
Paraguay
1
Venezuela
1
Palestine
1
Armenia
1
Laos
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Lithuania
1
Kyrgyzstan
1
Georgia
1
Mauritius
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
199
Women & Child Health
58
Public Health
50
Clinical Guidelines
48
Key Resources
47
Capacity Building
6
Pharmacy & Technologies
4
Toolboxes
Mental Health
57
Ebola
56
COVID-19
53
HIV
50
Planetary Health
45
Conflict
30
TB
30
Disability
28
Global Health Education
28
Rapid Response
27
Refugee
24
NTDs
24
Caregiver
20
Health Financing Toolbox
18
AMR
16
Pharmacy
13
Specific Hazards
7
Natural Hazards
5
NCDs
5
Polio
4
Cholera
3
Zika
2
Social Ethics
2
Typhoon
1
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on ... and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant and breastfeeding women, children and adolescents. The Global Action Plan has five strategic objectives: 1) prevention and response; 2) monitoring and surveillance; 3) research and innovation; 4) laboratory capacity; and 5) governance and enabling mechanisms.
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes ...
This publication aims to provide examples of better palliative care practices for older people to help those involved in planning and supporting care-oriented services most appropriately and effectively. Examples have been identifi ed from...
The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards ... goals, targets and milestones of the GTS. The central pillar of the framework is the adoption of programme phasing and transitioning, aimed at facilitating a tailored approach to malaria control/elimination. This is in response to the increasing heterogeneity of malaria epidemiology among and within countries of the region.
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths ... 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and over 46 000 new fatalities were reported globally – an increase of 25% and 21%, respectively, compared to the previous 28 days. As of 1 January 2023, over 656 million confirmed cases and over 6.6 million deaths have been reported globally.
In this edition, we include:
The COVID-19 epidemiological update at the global and regional levels.
An update on the circulating SARS-CoV-2 variants of concern (VOCs) and Omicron subvariants under monitoring.
An update on hospitalizations and ICU admissions related to COVID-19.
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into ... containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Resistance Surveillance System (GLASS), the first global collaborative effort to foster AMR surveillance in bacteria causing acute infections. As of December 2018, 71 countries are enrolled in GLASS. The aim of this report is to document participation efforts and outcomes across these countries, and highlight differences and constraints identified to date. This report follows on from the first GLASS Report – Early implementation 2016-17, published in January 2018, and drawing on data from GLASS first data call in 2017.
This new guideline on non-clinical interventions to reduce unnecessary caesarean sections incorporates the views, fears and beliefs of both women and heal... professionals about caesarean sections. It also considers the complex dynamics and limitations of health systems and organizations and relationships between women, health professionals and organization of health care services.
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigma...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the...
Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care sy...
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by ... World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-2020 period, recommended strategies, guiding principles, priorities, costing of reaching the targets, and the challenges as well as ways to overcome them.
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclus...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes ... impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence of steps in the continuum of care from HIV diagnosis to successful provision of ART services and outlines key supportive innovations. Chapter 4 discusses the implications and anticipated impact of the new "Consolidated guidelines on the use of ARV drugs for treating and preventing HIV infection
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, sev...
The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. Th... annual report provides an overview of the use and impact of the Fund over the previous year.
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-ri...
Vitamin D deficiency is thought to be common among pregnant women, particularly during the winter months, and has been found to be associated with an increased risk of pre-eclampsia, gestational dia...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing ... threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i) improve the detection of resistance to ensure a timely response; ii) delay the emergence of resistance to artemisinin and artemisinin-based combination therapy (ACT) partner drugs; and iii) limit the selection and spread of resistant parasites where resistance has been confirmed.
WHO Team
Global Malaria Programme
Editors
World Health Organization
Number of pages
87
Reference numbers
ISBN: 978 92 4 006026 5
Copyright
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides ... technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be used when the aim is to control or eliminate vector-borne diseases and can also contribute to insecticide resistance management. This toolkit provides information on where vector-borne diseases are endemic and what interventions should be used, presenting case studies on IVM as well as relevant guidance documents for reference.
The diseases that are the focus of this toolkit are malaria, lymphatic filariasis, dengue, leishmaniasis, onchocerciasis, human African trypanosomiasis and schistosomiasis. It also includes information on other viral diseases (Rift Valley fever, West Nile fever, Chikungunya, yellow fever) and trachoma. If other vector-borne diseases appear in a country or area, vector control with an IVM approach should be adopted, as per national priorities.
The toolkit provides ... technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be used when the aim is to control or eliminate vector-borne diseases and can also contribute to insecticide resistance management. This toolkit provides information on where vector-borne diseases are endemic and what interventions should be used, presenting case studies on IVM as well as relevant guidance documents for reference.
The diseases that are the focus of this toolkit are malaria, lymphatic filariasis, dengue, leishmaniasis, onchocerciasis, human African trypanosomiasis and schistosomiasis. It also includes information on other viral diseases (Rift Valley fever, West Nile fever, Chikungunya, yellow fever) and trachoma. If other vector-borne diseases appear in a country or area, vector control with an IVM approach should be adopted, as per national priorities.
